SCHEMBL17616574

SCHEMBL17616574

CCc1cc(C)ccc1OCc1ccccc1-n1nnn(C)c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.40
KDM4E B2RXH2 2/20 0.40
PTGER1 P34995 5/20 0.37
PTGER4 P35408 2/20 0.37
PTGER3 P43115 2/20 0.37
PTGER2 P43116 2/20 0.37
TSHR P16473 4/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 2/20 0.35
TP53 P04637 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
MAPK1 P28482 3/20 0.34
HPGD P15428 2/20 0.34
KDM5A P29375 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
ALDH1A1 P00352 3/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17616631 0.90 L3MBTL1 (0.44) L3MBTL1KDM4ETSHRLMNAMAPT
SCHEMBL16920779 0.89 L3MBTL1 (0.36) L3MBTL1KDM4EPTGER1PTGER4PTGER3
SCHEMBL15856645 0.89 HSP90AA1 (0.38) L3MBTL1PTGER1LMNAMAPTHPGD
SCHEMBL17616597 0.88 MRGPRX4 (0.43) L3MBTL1PTGER1TSHRMAPTTP53
SCHEMBL17616576 0.88 L3MBTL1 (0.43) L3MBTL1KDM4ETSHRLMNAMAPT
SCHEMBL8856034 0.87 MAPT (0.45) L3MBTL1KDM4ETSHRLMNAMAPT
SCHEMBL16920766 0.86 PTGER1 (0.34) L3MBTL1KDM4EPTGER1PTGER4PTGER3
SCHEMBL16920792 0.85 KDM4E (0.37) L3MBTL1KDM4EPTGER1TSHRLMNA
SCHEMBL17616572 0.85 FFAR1 (0.37) KDM4ELMNAMAPK1ALDH1A1
SCHEMBL16920801 0.84 PTGER1 (0.41) L3MBTL1KDM4EPTGER1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9675072-B2 Tetrazolinone compound and application of same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-06-13 US disclosed
US-20160081340-A1 TETRAZOLINONE COMPOUND AND APPLICATION OF SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160081340-A1 TETRAZOLINONE COMPOUND AND APPLICATION OF SAME CYP2E1, MT-CO2, CASP3 L3MBTL1 458/4885KDM4E 2537/4885PTGER1 3611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.